Syra Health Secures $660,000 Population Health Contract Extension
Syra Health (NASDAQ: SYRA) has secured a one-year, $660,000 Population Health contract extension with a national healthcare organization, bringing the total contract value to $1.32 million over two years.
The extension involves providing Healthcare Effectiveness Data and Information Set (HEDIS®) outreach and support services, focusing on improving healthcare quality, enhancing member outcomes, and reducing costs through data analysis and member outreach initiatives.
This renewal represents a continuation of services initially announced in March 2024 and supports the expansion of Syra Health's Population Health business unit, which is identified as a key growth contributor to the company's diversifying revenue base through higher-margin business segments.
Syra Health (NASDAQ: SYRA) ha ottenuto un'estensione di un anno del contratto di $660,000 per la Salute della Popolazione con un'organizzazione sanitaria nazionale, portando il valore totale del contratto a $1.32 milioni in due anni.
L'estensione prevede la fornitura di servizi di outreach e supporto per il Set di Dati e Informazioni sull'Effettività Sanitaria (HEDIS®), concentrandosi sul miglioramento della qualità dell'assistenza sanitaria, sul potenziamento dei risultati per i membri e sulla riduzione dei costi attraverso l'analisi dei dati e iniziative di outreach ai membri.
Questo rinnovo rappresenta una continuazione dei servizi inizialmente annunciati a marzo 2024 e supporta l'espansione dell'unità di business per la Salute della Popolazione di Syra Health, identificata come un contributore chiave alla crescita della base di entrate diversificata dell'azienda attraverso segmenti di business a margine più elevato.
Syra Health (NASDAQ: SYRA) ha asegurado una extensión de contrato de un año por $660,000 para la Salud de la Población con una organización de salud nacional, elevando el valor total del contrato a $1.32 millones en dos años.
La extensión implica la provisión de servicios de divulgación y apoyo del Conjunto de Datos e Información sobre la Efectividad de la Atención Médica (HEDIS®), enfocándose en mejorar la calidad de la atención médica, mejorar los resultados para los miembros y reducir costos a través del análisis de datos y las iniciativas de divulgación a los miembros.
Esta renovación representa una continuación de los servicios inicialmente anunciados en marzo de 2024 y apoya la expansión de la unidad de negocio de Salud de la Población de Syra Health, que se identifica como un contribuyente clave al crecimiento de la base de ingresos diversificada de la empresa a través de segmentos de negocio de mayor margen.
Syra Health (NASDAQ: SYRA)는 국가 의료 기관과 $660,000의 인구 건강 계약 연장을 체결하여 총 계약 가치를 2년 동안 $1.32 백만으로 증가시켰습니다.
이번 연장은 건강 관리 효과성 데이터 및 정보 세트(HEDIS®)의 아웃리치 및 지원 서비스를 제공하며, 데이터 분석 및 회원 아웃리치 이니셔티브를 통해 의료 품질 향상, 회원 결과 개선 및 비용 절감을 목표로 하고 있습니다.
이번 갱신은 2024년 3월에 처음 발표된 서비스의 연속성을 나타내며, Syra Health의 인구 건강 사업 부문의 확장을 지원하고 있으며, 이는 회사의 수익 다각화 기여에 중요한 성장 요소로 확인되고 있습니다.
Syra Health (NASDAQ: SYRA) a obtenu une prolongation de contrat d'un an d'un montant de $660,000 avec une organisation de santé nationale, portant la valeur totale du contrat à $1.32 million sur deux ans.
Cette prolongation implique la fourniture de services de sensibilisation et de soutien liés à l'ensemble de données et d'informations sur l'efficacité des soins de santé (HEDIS®), en se concentrant sur l'amélioration de la qualité des soins, l'amélioration des résultats pour les membres et la réduction des coûts grâce à l'analyse des données et aux initiatives de sensibilisation des membres.
Ce renouvellement représente une continuation des services initialement annoncés en mars 2024 et soutient l'expansion de l'unité commerciale de santé de la population de Syra Health, identifiée comme un contributeur clé à la croissance de la base de revenus diversifiée de l'entreprise à travers des segments d'activité à marge plus élevée.
Syra Health (NASDAQ: SYRA) hat eine einjährige Vertragsverlängerung über $660,000 für die Bevölkerungsmedizin mit einer nationalen Gesundheitsorganisation gesichert, wodurch der Gesamtwert des Vertrags auf $1,32 Millionen über zwei Jahre steigt.
Die Verlängerung umfasst die Bereitstellung von Outreach- und Unterstützungsdiensten für den Healthcare Effectiveness Data and Information Set (HEDIS®), mit dem Ziel, die Qualität der Gesundheitsversorgung zu verbessern, die Ergebnisse für die Mitglieder zu steigern und die Kosten durch Datenanalyse und Mitglieder-Outreach-Initiativen zu senken.
Diese Erneuerung stellt eine Fortsetzung der ursprünglich im März 2024 angekündigten Dienstleistungen dar und unterstützt die Expansion der Bevölkerungsmedizin-Sparte von Syra Health, die als wichtiger Wachstumsbeitrag zur diversifizierten Einnahmebasis des Unternehmens identifiziert wird, durch margenstärkere Geschäftsfelder.
- Secured $660,000 contract extension, doubling total contract value to $1.32 million
- Contract renewal demonstrates client satisfaction and service quality
- Expansion in higher-margin Population Health business segment
- None.
"We are pleased to continue securing valuable population health contract extensions, as demonstrated by this announcement," said Dr. Deepika Vuppalanchi, Chair and CEO of Syra Health. "This is a testament to the trust our partners place in us and highlights our ongoing ability to deliver impactful healthcare solutions that improve health outcomes. As we continue to secure such extensions, we are confident in our strategy to deliver long-term growth, expanded reach, and sustainable value creation."
Through the contract extension, Syra Health's team will continue providing Healthcare Effectiveness Data and Information Set (HEDIS®) outreach and support services. This extension enables Syra Health to further contribute to the organization's efforts to improve healthcare quality, enhance member outcomes, and reduce costs through expert data analysis and member outreach initiatives, as initially announced in March of 2024.
This contract extension supports the continued expansion of Syra Health's Population Health business unit, which is one of the key growth contributors to the company's diversifying revenue base. The success and renewal of these contracts align with Syra Health's strategic focus of strengthening its revenue streams through higher-margin business segments.
About Syra Health
Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology products and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit www.syrahealth.com.
Forward-Looking Statements
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts
For Media Inquiries:
Christine Drury
Corporate Communications Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Corbin Woodhull
Managing Director, Global Advisory
Hayden IR
602-476-1821
corbin@haydenir.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-secures-660-000-population-health-contract-extension-302400525.html
SOURCE Syra Health
FAQ
What is the value of Syra Health's latest Population Health contract extension?
What services will Syra Health provide under the extended contract?
When was the original contract with Syra Health (SYRA) initiated?
How does this contract extension align with Syra Health's (SYRA) business strategy?
